CNS & Neurological Disorders - Drug Targets

(Formerly Current Drug Targets - CNS & Neurological Disorders)

Stephen D. Skaper  
Department of Pharmaceutical and Pharmacological Sciences
University of Padova


Regulation of Neurogenesis and Gliogenesis by Stress and Antidepressant Treatment

Author(s): Mounira Banasr and Ronald S. Duman

Affiliation: Laboratory of Molecular Psychiatry, Yale University School of Medicine, 34 Park Street, Room S308, New Haven, CT 06508, USA.


Structural and morphological changes in limbic brain regions are associated with depression, chronic stress and antidepressant treatment, and increasing evidence supports the hypothesis that dysregulation of cell proliferation contributes to these effects. We review the morphological alterations observed in two brain regions implicated in mood disorders, the prefrontal cortex and hippocampus, and discuss the similarities and differences of the cellular consequences of chronic stress. We briefly discuss the proposed mechanisms implicated in neuroplasticity impairments that result from stress and that contribute to mood disorders, with a particular interest in adult neurogenesis and gliogenesis. This information has contributed to novel antidepressant medication development that utilizes adult neurogenesis and gliogenesis as preclinical cellular markers for predicting antidepressant properties of novel compounds.

Keywords: major depressive disorder, selective serotonin reuptake inhibitors, Hippocampal Volume, vascular endothelial growth factor, Glucocorticoids

Order Reprints Order Eprints Rights & PermissionsPrintExport

Article Details

Page: [311 - 320]
Pages: 10
DOI: 10.2174/187152707783220929